Trexquant Investment’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-17,258
Closed -$3.55M 1859
2022
Q4
$3.55M Buy
17,258
+14,321
+488% +$3.62M 0.1% 271
2022
Q3
$817K Buy
+2,937
New +$747K 0.03% 609
2022
Q2
Sell
-3,737
Closed -$775K 1954
2022
Q1
$775K Buy
+3,737
New +$616K 0.04% 580
2021
Q2
Sell
-3,376
Closed -$440K 1589
2021
Q1
$440K Sell
3,376
-1,861
-36% -$223K 0.04% 568
2020
Q4
$543K Sell
5,237
-1,063
-17% -$92.1K 0.06% 417
2020
Q3
$478K Buy
+6,300
New +$357K 0.03% 708

Other funds holding SWAV

Trexquant Investment's SWAV Position: Q1 2023 in Review

Trexquant Investment sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2023, closing a stake of 17,258 shares — an estimated $3.55M sold.

Trexquant Investment first reported a position in SWAV in Q3 2020 and held it in 6 quarters. The position peaked at $3.55M in Q4 2022. 381 funds tracked by Wall St. Rank hold SWAV as of Q1 2023.

  • Trexquant Investment reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Trexquant Investment sold 17,258 Shockwave Medical, Inc. Common Stock shares in Q1 2023, an estimated $3.55M.
  • Trexquant Investment first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
  • Trexquant Investment's Shockwave Medical, Inc. Common Stock position peaked at $3.55M in Q4 2022.
  • 381 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2023.

Based on Trexquant Investment's 13F filing for Q1 2023, filed 15 May 2023.